Vasoactive intestinal peptide downregulates the expression of IL-2 but not of IFNγ from stimulated murine T lymphocytes
- 30 September 1993
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 47 (2) , 147-158
- https://doi.org/10.1016/0165-5728(93)90025-t
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Inhibition of mouse T‐cell proliferation by CGRP and VIP: Effects of these neuropeptides on IL‐2 production and cAMP synthesisJournal of Neuroscience Research, 1991
- Human intraepithelial lymphocytesDigestive Diseases and Sciences, 1991
- Demonstration of immunoreactive vasoactive intestinal peptide (IR-VIP) and somatostatin (IR-SOM) in rat thymusBrain, Behavior, and Immunity, 1990
- Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.The Journal of Experimental Medicine, 1987
- Vasoactive intestinal peptide-containing nerves in Peyer's patchesBrain, Behavior, and Immunity, 1987
- CD4 receptor binding peptides that block HIV infectivity cause human monocyte chemotaxisFEBS Letters, 1987
- Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A.The Journal of Experimental Medicine, 1986
- Interaction of vasoactive intestinal peptide (VIP) with rat lymphoid cellsPeptides, 1986
- Specific binding of vasoactive intestinal peptide to human circulating mononuclear cellsCanadian Journal of Physiology and Pharmacology, 1983
- Interaction of vasoactive intestinal peptide with human blood mononuclear cellsMolecular and Cellular Endocrinology, 1981